Trends in lipid profiles in patients with psoriasis: a population-based analysis

BMC Dermatology

Volumn 12, Issue , 2012, Pages

  Akkara Veetil, Bharath M ^a   Matteson, Eric L ^a   Maradit Kremers, Hilal ^a   McEvoy, Marian T ^a   Crowson, Cynthia S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Epidemiology; Lipids; Psoriasis

Indexed keywords

ADALIMUMAB; ALEFACEPT; ANTILIPEMIC AGENT; AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; GOLIMUMAB; HIGH DENSITY LIPOPROTEIN; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; LEFLUNOMIDE; LIPID; LOW DENSITY LIPOPROTEIN; METHOTREXATE; RETINOID; SALAZOSULFAPYRIDINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; INCIDENCE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PSORIASIS; RANDOM SAMPLE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERUM; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; TIME FACTORS; TRIGLYCERIDES;

EID: 84867898134     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-12-20     Document Type: Article

References (26)

1. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007, 57:347-354. 10.1016/j.jaad.2007.02.007, 17433490.
2. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J 2010, 31:1000-1006. 10.1093/eurheartj/ehp567, 2894736, 20037179.
3. Kimball AB, Robinson D, Wu Y, Guzzo C, Yeilding N, Paramore C, et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology (Basel, Switzerland) 2008, 217:27-37.
4. Kimball AB, Wu Y. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol 2009, 48:1147-1156. 10.1111/j.1365-4632.2009.04075.x, 20064165.
5. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica chimica acta; international journal of clinical chemistry 2001, 303:33-39. 10.1016/S0009-8981(00)00358-2, 20705287.
6. Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD. Psoriasis and dyslipidaemia: a population-based study. Acta Derm Venereol 2008, 88:561-565.
7. Tekin NS, Tekin IO, Barut F, Sipahi EY. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediators Inflamm 2007, 2007:78454. 1804297, 17497039.
8. Farshchian M, Zamanian A, Monsef AR, Mahjub H. Serum lipid level in Iranian patients with psoriasis. J Eur Acad Dermatol Venereol 2007, 21:802-805. 10.1111/j.1468-3083.2006.02099.x, 17567311.
9. Vahlquist C, Michaelsson G, Vessby B. Serum lipoproteins in middle-aged men with psoriasis. Acta Derm Venereol 1987, 67:12-15.
10. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981, 245:54-63.
11. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester epidemiology project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004, 30:819-834. vii. 10.1016/j.rdc.2004.07.010, 15488695.
12. Maradit Kremers H, Myasoedova E, Crowson CS, Savova G, Gabriel SE, Matteson EL. The rochester epidemiology project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford) 2011, 50:6-15.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP).
14. Piskin S, Gurkok F, Ekuklu G, Senol M. Serum lipid levels in psoriasis. Yonsei Med J 2003, 44:24-26.
15. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006, 298:321-328. 10.1007/s00403-006-0703-z, 17021763.
16. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009, 145:700-703. 10.1001/archdermatol.2009.94, 19528427.
17. Gelfand JM, Mehta NN, Langan SM. Psoriasis and cardiovascular risk: strength in numbers, part II. J Invest Dermatol 2011, 131:1007-1010. 10.1038/jid.2011.32, 3426317, 21494241.
18. Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421. Third Report of the National Cholesterol Education Program (NCEP).
19. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006, 55:829-835. 10.1016/j.jaad.2006.08.040, 17052489.
20. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010, 69:1310-1314. 10.1136/ard.2009.122374, 2890039, 19854708.
21. Prodanovich S, Shelling ML, Federman DG, Kirsner RS. Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases. Arch Dermatol 2008, 144:1518-1519. 10.1001/archderm.144.11.1518, 19015432.
22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695. 10.1056/NEJMra043430, 15843671.
23. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 2009, 161:1-7.
24. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996, 49:223-233. 10.1016/0895-4356(95)00041-0, 8606324.
25. Akgun S, Ertel NH, Mosenthal A, Oser W. Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J Lab Clin Med 1998, 131:103-108. 10.1016/S0022-2143(98)90083-X, 9452133.
26. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005, 294:1773-1781. 10.1001/jama.294.14.1773, 16219880.